Ignite Creation Date:
2025-12-25 @ 2:33 AM
Ignite Modification Date:
2026-05-17 @ 6:25 AM
Study NCT ID:
NCT00121134
Status:
COMPLETED
Last Update Posted:
2013-12-24
First Post:
2005-07-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer
Sponsor:
Harold J. Burstein, MD, PhD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
05-055
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None